| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |